Why the Next Big Hope for Alzheimer’s Might Not Help Most Black Patients

With the FDA’s approval of lecanemab, Eisai is set to promote it to the primary care physicians who treat most dementia patients and critics are speaking out.

By Arthur Allen

July 7, 2023 Health Care

This story is republished from KFF Health News

OUR DIGITAL PARTNERS

Remote patient monitoring helps improve outcomes for seniors between visits

Why affordable housing is a healthcare issue

Integration is becoming the next competitive advantage in homecare

Why visa-based international hiring should be part of your staffing strategy